Loss of nuclear BAP1 protein expression is a marker of poor prognosis in patients with clear cell renal cell carcinoma.

[1]  A. Lopez‐Beltran,et al.  BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies , 2015, Expert review of molecular diagnostics.

[2]  J. Zeng,et al.  Cytoplasmic expression of BAP1 as an independent prognostic biomarker for patients with gliomas. , 2015, International journal of clinical and experimental pathology.

[3]  R. Hammer,et al.  Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis , 2014, Proceedings of the National Academy of Sciences.

[4]  J. Cheville,et al.  Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low‐risk clear cell renal cell carcinoma , 2014, Cancer.

[5]  N. Naus,et al.  Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma , 2014, Modern Pathology.

[6]  K. Bensalah,et al.  BAP1 immunohistochemistry predicts outcomes in a multi-institutional cohort with clear cell renal cell carcinoma. , 2014, The Journal of urology.

[7]  J. Brugarolas.  PBRM1 and BAP1 as novel targets for renal cell carcinoma. , 2013, Cancer journal.

[8]  G. Gyapay,et al.  Germline BAP1 mutations predispose to renal cell carcinomas. , 2013, American journal of human genetics.

[9]  N. Grishin,et al.  A Novel Germline Mutation in BAP1 Predisposes to Familial Clear-Cell Renal Cell Carcinoma , 2013, Molecular Cancer Research.

[10]  P. Kapur,et al.  Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation. , 2013, The Lancet. Oncology.

[11]  H. Moch,et al.  Loss of PBRM1 expression is associated with renal cell carcinoma progression , 2013, International journal of cancer.

[12]  N. Grishin,et al.  BAP1 loss defines a new class of renal cell carcinoma , 2012, Nature Genetics.

[13]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.

[14]  Huanming Yang,et al.  Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma , 2011, Nature Genetics.

[15]  D. Roukos.  Innovation versus evidence: to trust direct-to-consumer personal genomic tests? , 2011, Expert review of molecular diagnostics.

[16]  P. A. Futreal,et al.  Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma , 2010, Nature.

[17]  G. Hart,et al.  The Ubiquitin Carboxyl Hydrolase BAP1 Forms a Ternary Complex with YY1 and HCF-1 and Is a Critical Regulator of Gene Expression , 2010, Molecular and Cellular Biology.

[18]  Gurpreet W. Tang,et al.  Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes , 2009, Nature.

[19]  A. Lopez‐Beltran,et al.  2009 update on the classification of renal epithelial tumors in adults , 2009, International journal of urology : official journal of the Japanese Urological Association.

[20]  V. Dixit,et al.  Association of C-Terminal Ubiquitin Hydrolase BRCA1-Associated Protein 1 with Cell Cycle Regulator Host Cell Factor 1 , 2009, Molecular and Cellular Biology.

[21]  Erwin G. Van Meir,et al.  BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization. , 2008, Cancer research.

[22]  D. Angeloni.  Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease. , 2007, Briefings in functional genomics & proteomics.

[23]  S. Fuhrman,et al.  Prognostic significance of morphologic parameters in renal cell carcinoma , 1982, The American journal of surgical pathology.

[24]  J. Cheville,et al.  Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinoma. , 2015, Urologic oncology.

[25]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.